Zuberitamab for EBV Infection Post-Allo-HSCT
Zuberitamab for EBV Infection Post-Allo-HSCT
Not yet recruiting · NCT07261215 · Registry updated 2025-12-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zuberitamab for EBV Infection Post-Allo-HSCT | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, viral infectious disease | Not yet recruiting | Phase 2 | 2025-12-03 | NCT07261215 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||